Coca-Cola’s Financial Results Beat Wall Street Estimates
Beverage giant Coca-Cola (KO) has reported quarterly financial results that beat Wall Street forecasts across the board as demand for its drinks rises.The Atlanta, Georgia-based company announced earnings per share (EPS) of $0.55 U.S., which topped the $0.52 U.S. consensus expectation of analysts.Revenue in the period totaled $11.54 billion U.S., which was above the $10.68 billion U.S. anticipated on Wall Street. Sales increased 6% from a year earlier.The soft drink maker attributed the strong results to its expansion in emerging markets such as India and partnerships in North America.In the U.S., Coca-Cola's partnerships with fast-food chains such as McDonald's (MCD) have helped to drive sales.Coke has also invested in its sparkling water label Topo Chico and Fairlife milk.Looking ahead, the company said it expects organic revenue growth for 2025 of 5% to 6%. That’s about half the 12% growth achieved for all of 2024. However, Coca-Cola’s 2025 guidance is at the higher end of the company's long-term organic revenue growth target of between 4% and 6%.The stock of Coca-Cola has risen 8% over the past 12 months to trade at $64.55 U.S. per share.
Recent Posts

Europe Faces Most Difficult Moment in Bid to Avoid Split With US

Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients

Hastings Racecourse in Vancouver to shut down permanently, operator says

Russia’s Vital Oil Trade With India Is Down, But Not Out

Copper Quest Closes $1,927,000 Private Placement

This TSX stock was up 17% this week and it could gain another 36%, analysts say

AMC Entertainment Holdings, Inc. Transfers the Majority of its Equity Investment in Hycroft Mining Holding Corporation to Sprott Mining for a Net Consideration of $24.1 million

Guardian Capital Announces Estimated 2025 Annual Non-Cash Distributions for Guardian Capital ETFs

Emera Renews At-The-Market Equity Program

CRA warns of ‘aggressive tax schemes’ involving critical illness insurance


